News‎ > ‎Full Stories‎ > ‎

3 April 2017

posted Apr 3, 2017, 3:17 AM by Beck Lockwood   [ updated Jul 25, 2017, 10:46 PM ]
Poster competition win for AKI Diagnostics team

A poster outlining research by NIHR DEC Leeds to evaluate new tests for the diagnosis of acute kidney injury has won first prize at an international conference on molecular medicine.

The AKI Diagnostics project poster was presented at Molecular Med Tri-Con 2017 in San Francisco in February, a conference that brings together professionals from industry, healthcare and academia to focus on discovery, genomics, diagnostics and information technology.

NIHR DEC Leeds Health Economist, Alison Smith, who led the study, explains: “We identified which commercially available tests look the most promising, based on the existing research and then determined what further studies would be needed, to provide an evidence base on which the healthcare provider could make an informed decision.”

Mike Messenger, Deputy Director of NIHR DEC Leeds, added: “Researchers often focus their efforts around generating evidence on the diagnostic accuracy of a test.  This evaluation nicely shows how the uncertainty around many other factors, such as the incidence or prevalence of a disease, or the effectiveness of interventions, can have a big impact on the estimated cost-effectiveness of a test. 

"Identifying these factors early enables us to ensure that subsequent research efficiently targets the information that’s needed by the health and care system, so ultimately commissioners are able to decide more quickly on adoption of these technologies.”

A podcast interview with Dr Smith and Dr Messenger is available here.